The Potential of MicroRNAs as Non-Invasive Prostate Cancer Biomarkers: A Systematic Literature Review Based on a

Emilia Bevacqua1, Salvatore Ammirato2, Erika Cione1

  • 1Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.

Cancers
|November 11, 2022
PubMed
Summary

This study reviews microRNAs (miRs) as potential biomarkers for prostate cancer (PCa) diagnosis. Urine-based miR detection shows promise as a reliable, non-invasive tool for PCa detection, offering an alternative to the less specific prostate-specific antigen (PSA) test.